Published in Clinical Oncology Week, April 10th, 2006
According to recent research from Japan, "Vascular endothelial growth factor-C (VEGF-C) is thought to be an important factor in tumor angiogenesis/lymphangiogenesis, but its role in hepatocellular carcinoma (HCC) has not yet been fully investigated. We immunohistochemically examined VEGF-C expression in surgically resected tissues of 90 HCC."
"In the 78 HCC with a single histological grade, VEGF-C expression was significantly stronger in poorly differentiated HCC than in well- (p=.003) or moderately-differentiated HCC (p=.0002)," reported R. Yamaguchi and colleagues, Kurume University.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.